Damora Therapeutics, Inc. (DMRA) vs Nektar Therapeutics (NKTR)
A side-by-side comparison of Damora Therapeutics, Inc. and Nektar Therapeutics across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$18.96HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
NKTR
Nektar Therapeutics
$40.16HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — DMRA vs NKTR
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)NKTR -82.3% (-25.1%/yr)NKTR compounded faster over this window
DMRA NKTR
DMRA vs NKTR: by the numbers
- •DMRA is the larger company ($1.17B vs $1.15B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -287.84% net margin).
Metrics side by side
Valuation
| Metric | DMRA | NKTR |
|---|---|---|
| P/S ratio | N/A | 21.10 |
| P/B ratio | 3.02 | 1.28 |
Profitability
| Metric | DMRA | NKTR |
|---|---|---|
| Gross margin | 0.00% | 99.36% |
| Operating margin | 0.00% | -240.38% |
| Net margin | 0.00% | -287.84% |
| ROE | -50.93% | -17.40% |
| ROIC | -52.44% | -12.53% |
Growth (annualized)
| Metric | DMRA | NKTR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -12.34% |
| Total return CAGR (5Y) | -25.05% | -30.33% |
Frequently asked
- How have DMRA and NKTR total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and NKTR delivered -30.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.